1. Home
  2. GKOS vs TAP Comparison

GKOS vs TAP Comparison

Compare GKOS & TAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Glaukos Corporation

GKOS

Glaukos Corporation

HOLD

Current Price

$153.58

Market Cap

9.0B

Sector

Health Care

ML Signal

HOLD

Logo Molson Coors Beverage Company Class B

TAP

Molson Coors Beverage Company Class B

HOLD

Current Price

$40.95

Market Cap

8.5B

ML Signal

HOLD

Company Overview

Basic Information
Metric
GKOS
TAP
Founded
1998
1873
Country
United States
United States
Employees
N/A
16200
Industry
Medical/Dental Instruments
Beverages (Production/Distribution)
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
9.0B
8.5B
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
GKOS
TAP
Price
$153.58
$40.95
Analyst Decision
Strong Buy
Hold
Analyst Count
12
17
Target Price
$126.92
$48.94
AVG Volume (30 Days)
692.4K
2.9M
Earning Date
04-29-2026
04-30-2026
Dividend Yield
N/A
4.53%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$507,442,000.00
N/A
Revenue This Year
$23.32
$0.85
Revenue Next Year
$27.43
$0.17
P/E Ratio
N/A
N/A
Revenue Growth
32.33
N/A
52 Week Low
$73.16
$38.04
52 Week High
$161.53
$54.82

Technical Indicators

Market Signals
Indicator
GKOS
TAP
Relative Strength Index (RSI) 61.97 53.50
Support Level $96.44 $40.79
Resistance Level $161.53 $42.65
Average True Range (ATR) 5.46 1.27
MACD -0.85 0.17
Stochastic Oscillator 55.40 55.25

Price Performance

Historical Comparison
GKOS
TAP

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. The company has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

About TAP Molson Coors Beverage Company Class B

Molson Coors owns well-known beer brands including Miller, Coors, Blue Moon, and Carling, and ranks as the second-largest beer maker in both value and volume in the US, Canada, and the United Kingdom. Through licensing agreements, it also brews and distributes beer and nonbeer beverage categories under partner brands from Heineken, Anheuser-Busch InBev, Asahi, Fever-Tree, and Coca-Cola. North America remains its largest market, accounting for nearly 80% of total revenue.

Share on Social Networks: